A Comparative Analysis of Biosimilar vs. Originator Filgrastim in Combination With Plerixafor for Stem Cell Mobilization in Lymphoma and Multiple Myeloma: A Propensity-Score Weighted Multicenter Approach

American Journal of Hematology- United States

doi 10.1002/ajh.24817

Full Text

Abstract

Available in

Categories

Hematology

Date

Authors

Publisher

Wiley

Related search

Efficacy and Safety of Plerixafor for Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Patients With Non‑Hodgkin Lymphoma and Multiple Myeloma: A Systematic Review and Meta‑analysis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Cost Analysis of a Randomized Stem Cell Mobilization Study in Multiple Myeloma

Annals of Hematology
MedicineHematology
2016English

Plerixafor for Stem Cell Mobilization in Allogeneic Stem Cell Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Hematopoietic Stem Cell Mobilization With Plerixafor in Sickle Cell Disease

Haematologica
Hematology
2018English

Stem Cell Mobilization and Autograft Purity With Novel Induction Regimens in Multiple Myeloma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Stem Cells International
Cell BiologyMolecular Biology
2012English

Tbo-Filgrastim Versus Filgrastim During Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study

BioDrugs
MedicineBiotechnologyPharmacology
2018English

Mobilization and Transplantation Patterns of Autologous Hematopoietic Stem Cells in Multiple Myeloma and Non-Hodgkin Lymphoma

Cancer Control
MedicineOncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy